GO
Loading...

The Battle Against Diabetes

Tuesday, 9 Jan 2007 | 10:17 AM ET

Amylin Pharmaceuticals CEO Ginger Graham discusses her company's diabetes drug, Byetta, with CNBC's Mike Huckman.